Limit Quinolones Due to Aortic Aneurysm and Rupture Risks
Rupture of aortic aneurysm is the latest quinolone risk...leading FDA to require added warnings on oral and injectable quinolone labels.
Aortic aneurysm and rupture are rare...and may occur in about one in every 11,000 patients overall each year. But they can be fatal.
That number can jump to one in about 300 high-risk patients. This includes the elderly...patients with a history of aneurysm, hypertension, vascular disease, or smoking...or those with some genetic conditions.